Nevertheless, once the same scientists at LIH done a prior review, they identified an atypical opioid receptor referred to as ACKR3.Additionally, the conolidine molecule didn't interact with the classical receptors, that means that it would not compete from opioid peptides to bind to these receptors.efficacy and Uncomfortable side effects or toxici